NASDAQ$SKIN

SkinHealth Systems Inc · Q1 2025 earnings

Q1 2025 earnings · · After market close · Investor relations

Briefing

SKIN reported Q1 2025 revenue of $69.6M, a net loss of $10.1M, diluted EPS of -0.08.

For Q1 2025, SKIN reported Revenue was $69.6M, net loss was $10.1M, diluted EPS was -0.08. Management discusses segment trends, liquidity, and outlook in the quarterly filing.

  • Revenue $69.6M for Q1 2025.
  • Net loss $10.1M.
  • Diluted EPS -0.08.

Headline financials

Total Revenue

$69.6M

Previous: $81.4M-14.5%
EPS (adj)

-$0.08

Previous: -$0.10+20.0%
Gross Margin

69.8%

Previous: 59.4%+17.5%
Adjusted EBITDA

$7.3M

Previous: $400K+1725.0%
Adjusted EBITDA Margin

10.4%

Previous: 0.4%+2500.0%
Adjusted Gross Profit

$50M

Previous: $51.6M-3.1%
Adjusted Gross Margin

71.9%

Previous: 63.4%+13.4%
Total Delivery Systems Sold

862

Previous: 1.4K-39.2%
Active Install Base

35.0K

Previous: 32.5K+7.6%
Capital Expenditures

-$45K

Previous: -$344K+86.9%
Net Income

-$10.1M

Previous: -$679K-1386.9%
Operating Income

-$12M

Previous: -$17M+29.4%
Gross Profit

$48.6M

Previous: $48.4M+0.5%

Revenue & EPS history

Beauty Health · Revenue · Quarterly

$69.6M

Q1 2025-14.5%vs Q1 2024
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Revenue by segment

Beauty Health · $97.4M total across 2 segments · Q3 2023

  • Delivery Systems
    $51M+3.9%
  • Consumables
    $46.4M+16.9%

Forward guidance

Outlook emphasizes liquidity, cost control, and path to profitability.

Tailwinds

  • Revenue initiatives and operating leverage potential.
  • Balance-sheet flexibility from cash or credit.

Headwinds

  • Continued operating losses.
  • Macro or one-time items affecting comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

+0.6%

Avg return

Earnings day

-0.5%

Avg return

5 days after

-1.9%

Avg return

30 days after

52%

12 / 23 earnings

Positive

+52.1%

Q1 2025

Best reaction

-61.4%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.5%-29.9%-34.9%
Q4 2025+19.8%+11.3%-15.3%
Q3 2025+8.7%+3.1%+13.2%
Q1 2025+52.1%+19.4%+29.0%
Q4 2024-5.6%-9.9%-26.1%
Q3 2024+5.1%-13.1%-14.2%
Q2 2024-10.4%+0.8%+12.8%
Q1 2024-20.1%-18.4%-39.9%
Q4 2023+16.8%-0.8%+4.4%
Q3 2023-61.4%-37.2%-14.7%
Q2 2023-6.0%-12.9%-24.2%
Q1 2023-2.8%-0.2%-20.8%
Q4 2022+8.7%+13.5%+7.4%
Q3 2022-25.3%-12.3%-4.1%
Q2 2022-8.3%-8.8%-18.5%
Q1 2022-5.4%+6.6%+8.9%
Q4 2019+4.0%-4.1%-12.9%
Q4 2021+23.4%+43.1%+27.6%
Q3 2021-11.9%-8.0%-13.9%
Q2 2020+8.2%+7.4%+26.8%
Q2 2021+10.6%+23.9%+30.3%
Q1 2021+12.8%+15.9%+44.7%
Q4 2020+2.8%-0.9%-10.0%
Q3 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro